Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside

This publication has 26 references indexed in Scilit:

• Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine
  Annals of Surgery, 1992
• Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules.
  Proceedings of the National Academy of Sciences, 1991
• Role of Gangliosides in Active Immunotherapy with Melanoma Vaccine
  International Reviews of Immunology, 1991
• Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients
  Annals of Surgery, 1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Stage II malignant melanoma: Presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients
  Journal of Surgical Oncology, 1988
• Gangliosides as antigens of human melanoma
  Published by Springer Nature ,1988
• Phase-I study of intravenous modified lipid A
  Cancer Immunology, Immunotherapy, 1984
• A Two-Step Mechanism for the Interaction of Re Lipopolysaccharide with Erythrocyte Membranes
  Clinical Infectious Diseases, 1984
• BCG and Cancer
  New England Journal of Medicine, 1974